BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 27374666)

  • 1. Pretreatment serum GH levels and cardio-metabolic comorbidities in acromegaly; analysis of data from Iran Pituitary Tumor Registry.
    Hedayati Zafarghandi L; Khamseh ME; Fooladgar M; Mohseni S; Qorbani M; Madani NH; Hemmatabadi M; Mohajeri-Tehrani M; Shirzad N
    J Diabetes Metab Disord; 2020 Jun; 19(1):319-325. PubMed ID: 32550182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and associated risk factors of detectable renal morphological abnormalities in acromegaly.
    Bostan H; Kizilgul M; Calapkulu M; Kalkisim HK; Topcu FBG; Gul U; Duger H; Hepsen S; Ucan B; Cakal E
    Pituitary; 2024 Feb; 27(1):44-51. PubMed ID: 38064149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare complication: Infection in acromegalic renal cysts.
    Mori Y; Otsuka Y; Nakano Y; Sakae H; Hasegawa K; Otsuka F
    Clin Case Rep; 2020 Dec; 8(12):3551-3552. PubMed ID: 33363973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acromegaly and ultrasound: how, when and why?
    Parolin M; Dassie F; Vettor R; Maffei P
    J Endocrinol Invest; 2020 Mar; 43(3):279-287. PubMed ID: 31502218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional prevalence of pancreatic cystic lesions in patients with acromegaly, a single-center experience.
    Odake Y; Fukuoka H; Yamamoto M; Arisaka Y; Konishi J; Yoshida K; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Yamada S; Ogawa W; Takahashi Y
    Pituitary; 2017 Oct; 20(5):509-514. PubMed ID: 28540626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets.
    Iaconis D; Monti M; Renda M; van Koppen A; Tammaro R; Chiaravalli M; Cozzolino F; Pignata P; Crina C; Pucci P; Boletta A; Belcastro V; Giles RH; Surace EM; Gallo S; Pende M; Franco B
    Sci Rep; 2017 Apr; 7(1):1224. PubMed ID: 28450740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Simple Renal Cysts in Acromegaly.
    Yamamoto M; Matsumoto R; Fukuoka H; Iguchi G; Takahashi M; Nishizawa H; Suda K; Bando H; Takahashi Y
    Intern Med; 2016; 55(13):1685-90. PubMed ID: 27374666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
    Serri O; Beauregard C; Hardy J
    J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?
    Dobri G; Niwattisaiwong S; Bena JF; Gupta M; Kirwan J; Kennedy L; Hamrahian AH
    Endocrine; 2019 Apr; 64(1):139-146. PubMed ID: 30415402
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.